Flexibility to dose PRN, once or twice a day versus the leading allergy spray products that recommend daily dosing schedules that may not match patient usage behavior1,2,*




Many patients may use INS sprays incorrectly, reaching for them only when symptoms arise.
Of the nasal spray users (n=732) in a survey, conducted by Bayer®, of patients taking medication for their allergies (N=1202)1:

  • 42% said they administer INS sprays “some days and not others”
  • More than one-third reported administering a spray as soon as they experienced symptoms


INS, intranasal steroid.
*In a survey of allergy patients that included nasal spray users (n=732), 42% of patients said they administer their INS “some days and not others.”

1. Data on file. Bayer. Habits and practices. 2. NDA 213872. 3. Ortiz G, Knutdtson M. Counseling patients on the use of intranasal steroids in allergic rhinitis management. Consultant. 2017;57(6):328-334.